Provided herein is use HIF prolyl hydroxylase inhibitors treating or preventing given dose and dosage regimen in anaemia, the anaemia is, for example, chronic kidney disease is secondary or the anaemia of correlation, non-dialysis dependence chronic kidney disease are secondary or anaemia, the chemotherapy of correlation are relevant or the anaemia as caused by chemotherapy or anaemia relevant to AIDS.